Incannex Healthcare IXHL
NASDAQ IXHL
$3.57 -0.05 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) Change in Account Payables (2023 - 2024)

Incannex Healthcare (IXHL) posted Change in Account Payables of $2.7 million for Q2 2024, up 1447.03% sequentially from -$202000.0 in Q1 2024, and up 69.22% YoY from $1.6 million in Q3 2023.

Incannex Healthcare (IXHL) Change in Account Payables (2023 - 2024) Analysis & Trends

Incannex Healthcare has reported Change in Account Payables for 2 years, with the latest figure at $2.7 million in Q2 2024.

  • Quarterly Change in Account Payables rose 69.22% year-over-year to $2.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $4.3 million (changed N/A YoY) and the FY2024 annual result came in at $3.0 million, up 173.82% from the prior year.
  • Change in Account Payables climbed to $2.7 million in Q2 2024 per IXHL's latest filing, from -$202000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $2.7 million in Q2 2024 and troughed at -$202000.0 in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Incannex Healthcare 44.39 Mn 44.39 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 2.72 Mn
Jun 30, 2024 2.72 Mn
Mar 31, 2024 -202,000.00
Mar 31, 2024 -202,000.00
Jun 30, 2023 1.61 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 131,000.00
Mar 31, 2023 131,000.00